Tenon Medical reported revenue of $1.28M and net income of -$4.05M for the quarter ended Jun 2026, up 126.8% year over year. This income statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||
| Revenue | 0.07M | 0.05M | 0.07M | 0.14M | 0.21M | 0.28M | 0.43M | 0.74M | 0.94M | 0.81M | 0.72M | 0.90M | 0.89M | 0.77M | 0.73M | 0.56M | 1.17M | 1.48M | 1.38M | 1.28M | ||
| Cost of RevenueCost of Rev | 0.02M | 0.02M | 0.28M | 0.27M | 0.30M | 0.48M | 0.48M | 0.55M | 0.41M | 0.25M | 0.25M | 0.43M | 0.47M | 0.42M | 0.40M | 0.32M | 0.40M | 0.46M | 0.43M | 0.47M | ||
| Gross Profit | 0.05M | 0.04M | -0.20M | -0.14M | -0.09M | -0.21M | -0.05M | 0.19M | 0.54M | 0.56M | 0.47M | 0.47M | 0.42M | 0.35M | 0.32M | 0.24M | 0.77M | 1.02M | 0.94M | 0.81M | ||
| Operating items | ||||||||||||||||||||||
| Research & DevelopmentR&D | 0.60M | 0.67M | 0.56M | 1.94M | 0.80M | 4.60M | 2.03M | 1.88M | 1.53M | 1.34M | 1.38M | 1.45M | 1.21M | 1.07M | 1.65M | 1.12M | 1.54M | 1.72M | 1.86M | 1.87M | ||
| Selling, General & AdministrativeSG&A | 0.99M | 1.14M | 1.04M | 2.72M | 1.73M | 1.94M | 1.98M | 1.73M | 1.65M | 1.67M | 1.93M | 2.19M | 1.76M | 1.89M | 1.66M | 1.48M | 2.20M | 1.63M | 1.71M | 1.53M | ||
| Other Operating ExpensesOther Opex | 0.56M | 0.79M | 0.28M | 0.66M | 0.65M | 1.18M | 0.83M | 0.90M | 0.74M | 0.69M | 0.67M | 0.71M | 0.66M | 0.57M | 0.69M | 0.50M | 0.43M | 0.53M | 0.66M | 0.77M | ||
| Operating ExpensesOpex | 2.15M | 2.60M | 1.88M | 5.32M | 3.17M | 7.72M | 4.84M | 4.52M | 3.91M | 3.70M | 3.98M | 4.34M | 3.63M | 3.53M | 4.00M | 3.10M | 4.17M | 3.88M | 4.22M | 4.17M | ||
| Operating IncomeOp. Inc | -2.10M | -2.56M | -2.08M | -5.46M | -3.26M | -7.93M | -4.89M | -4.32M | -3.38M | -3.14M | -3.51M | -3.87M | -3.21M | -3.17M | -3.68M | -2.86M | -3.39M | -2.87M | -3.28M | -3.35M | ||
| EBIT | -2.10M | -2.56M | -2.08M | -5.46M | -3.26M | -7.93M | -4.89M | -4.32M | -3.38M | -3.14M | -3.51M | -3.87M | -3.21M | -3.17M | -3.68M | -2.86M | -3.39M | -2.87M | -3.28M | -3.35M | ||
| Non-operating items | ||||||||||||||||||||||
| Non Operating Interest Expenses | 0.27M | 0.28M | 0.27M | 0.09M | -0.01M | 0.00M | 0.02M | 0.06M | -0.03M | 0.18M | 0.85M | |||||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | 0.00M | 0.00M | 0.00M | 0.04M | 0.07M | 0.07M | 0.06M | 0.04M | 0.05M | 0.02M | 0.03M | 0.04M | 0.03M | 0.09M | 0.06M | 0.09M | 0.05M | 0.03M | 0.03M | 0.02M | ||
| Interest & Investment IncomeInt & Inv Inc | 0.00M | |||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.00M | 0.02M | 0.02M | -0.06M | -0.06M | 0.01M | -0.04M | 0.13M | ||||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.27M | -0.28M | -0.27M | -0.03M | 0.09M | 0.02M | 0.06M | 0.04M | 0.05M | 0.01M | -0.07M | 0.05M | 0.03M | 0.09M | 0.06M | 0.09M | 0.05M | 0.03M | -0.20M | -0.70M | ||
| Net income details | ||||||||||||||||||||||
| EBT | -2.36M | -2.84M | -2.35M | -5.54M | -3.26M | -7.92M | -4.89M | -4.32M | -3.38M | -3.16M | -3.57M | -3.84M | -3.21M | -3.17M | -3.68M | -2.86M | -3.39M | -2.87M | -3.46M | -4.21M | ||
| Profit After TaxPAT | -2.36M | -2.84M | -2.35M | -5.54M | -3.20M | -7.84M | -4.83M | -4.29M | -3.33M | -3.13M | -3.58M | -3.83M | -3.18M | -3.09M | -3.62M | -2.77M | -3.34M | -2.83M | -3.48M | -4.05M | ||
| Income from Non-Controlling InterestsInc. Minority | -0.02M | |||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -2.36M | -2.84M | -2.35M | -5.54M | -3.26M | -7.92M | -4.89M | -4.32M | -3.38M | -3.16M | -3.57M | -3.84M | -3.21M | -3.17M | -3.68M | -2.86M | -3.39M | -2.87M | -3.46M | -4.21M | ||
| Consolidated Net IncomeConsol Net Inc. | -2.36M | -2.84M | -2.35M | -5.54M | -3.26M | -7.92M | -4.89M | -4.32M | -3.38M | -3.16M | -3.57M | -3.84M | -3.21M | -3.17M | -3.68M | -2.86M | -3.39M | -2.87M | -3.46M | -4.21M | ||
| Income towards Parent CompanyParent Net Inc | -2.36M | -2.84M | -2.35M | -5.54M | -3.26M | -7.92M | -4.89M | -4.32M | -3.38M | -3.16M | -3.57M | -3.84M | -3.21M | -3.17M | -3.68M | -2.86M | -3.39M | -2.87M | -3.46M | -4.21M | ||
| Net Income towards Common StockholdersNet Income | -2.36M | -2.84M | -2.35M | -5.54M | -3.26M | -7.92M | -4.89M | -4.32M | -3.38M | -3.16M | -3.57M | -3.84M | -3.21M | -3.17M | -3.68M | -2.86M | -3.39M | -2.87M | -3.46M | -4.21M | ||
| Additional items | ||||||||||||||||||||||
| EPS (Basic) | -0.01M | -0.01M | -0.01M | -0.00M | -812.86 | -0.00M | -0.00M | -926.63 | -416.04 | -487.42 | -350.28 | -287.03 | -128.31 | -91.48 | -35.78 | -13.17 | -14.39 | -13.58 | -10.73 | -12.82 | ||
| EPS (Diluted) | -0.01M | -0.01M | -0.01M | -0.00M | -812.86 | -0.00M | -0.00M | -926.63 | -416.04 | -487.42 | -350.28 | -287.03 | -128.31 | -91.48 | -35.78 | -13.17 | -14.39 | -13.58 | -10.73 | -12.82 | ||
| Shares Outstanding | 328.00 | 322.00 | 354.00 | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.03M | 0.03M | 0.10M | 0.22M | 0.24M | 0.21M | 0.32M | 0.33M | ||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 328.00 | 322.00 | 354.00 | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.03M | 0.03M | 0.10M | 0.22M | 0.24M | 0.21M | 0.32M | 0.33M | ||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 338.00 | 354.00 | 354.00 | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.03M | 0.03M | 0.10M | 0.22M | 0.25M | 0.21M | 0.32M | 0.33M | ||
| EBITDA | -2.10M | -2.56M | -2.08M | -5.46M | -3.26M | -7.93M | -4.89M | -4.32M | -3.38M | -3.14M | -3.51M | -3.87M | -3.21M | -3.17M | -3.68M | -2.86M | -3.39M | -2.87M | -3.28M | -3.35M | ||
| Interest ExpensesInt Expense | 0.27M | 0.28M | 0.27M | 0.09M | -0.01M | 0.00M | 0.02M | 0.06M | -0.03M | 0.18M | 0.85M |